ReviewFrontiers in oncology2023

Double trouble for prostate cancer: synergistic action of AR blockade and PARPi in non-HRR mutated patients.

Alexander Giesen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.